Vitamin B 12-Mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa

Infection and Immunity

Volumn 80, Issue 5, 2012, Pages 1639-1649

  Lee, Kang Mu ^a   Go, Junhyeok ^a   Yoon, Mi Young ^a   Park, Yongjin ^a   Kim, Sang Cheol ^a   Yong, Dong Eun ^a   Yoon, Sang Sun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CYANOCOBALAMIN; RIBONUCLEOTIDE REDUCTASE; TRANSCRIPTOME; BACTERIAL DNA; VITAMIN B COMPLEX;

ANAEROBIC GROWTH; BACTERIAL STRAIN; BIOFILM; CELL DENSITY; CELL DIVISION; CELL ELONGATION; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; DNA CONTENT; DNA REPLICATION; DOWN REGULATION; GENETIC TRANSCRIPTION; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PSEUDOMONAS AERUGINOSA; SHORT SURVEY; STRESS; AEROBIC METABOLISM; ARTICLE; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; OXYGEN CONSUMPTION; PHYSIOLOGY; PROTEIN MICROARRAY;

AEROBIOSIS; ANAEROBIOSIS; BIOFILMS; DNA, BACTERIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; OXYGEN CONSUMPTION; PROTEIN ARRAY ANALYSIS; PSEUDOMONAS AERUGINOSA; RIBONUCLEOTIDE REDUCTASES; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 84861114062     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06161-11     Document Type: Short Survey

References (63)

1. Arai H, Igarashi Y, Kodama T. 1994. Structure and ANR-dependent transcription of the nir genes for denitrification from Pseudomonas aeruginosa. Biosci. Biotechnol. Biochem. 58:1286-1291.
2. Arai H, Kodama T, Igarashi Y. 1998. The role of the nirQOP genes in energy conservation during anaerobic growth of Pseudomonas aeruginosa. Biosci. Biotechnol. Biochem. 62:1995-1999.
3. Blakley RL. 1966. Cobamides and ribonucleotide reduction. J. Biol. Chem. 241:176-179.
4. Boucher RC. 2004. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur. Respir. J. 23:146-158.
5. Burton P, Holland IB. 1983. Two pathways of division inhibition in UV-irradiated E. coli. Mol. Gen. Genet. 190:309-314.
6. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
7. Deren JJ, Arora B, Toskes PP, Hansell J, Sibinga MS. 1973. Malabsorption of crystalline vitamin B 12 in cystic fibrosis. N. Engl. J. Med. 288:949-950.
8. Donachie WD, Begg KJ. 1989. Cell length, nucleoid separation, and cell division of rod-shaped and spherical cells of Escherichia coli. J. Bacteriol. 171:4633-4639.
9. Donaldson SH, Boucher RC. 2003. Update on pathogenesis of cystic fibrosis lung disease. Curr. Opin. Pulm. Med. 9:486-491.
10. Drapeau GR, Gariepy F, Boule M. 1984. Regulation and SOS induction of division inhibition in Escherichia coli K12. Mol. Gen. Genet. 193:453-458.
11. Durie PR, Pencharz PB. 1989. A rational approach to the nutritional care of patients with cystic fibrosis. J. R. Soc. Med. 82(Suppl. 16):11-20.
12. Elledge SJ, Davis RW. 1989. DNA damage induction of ribonucleotide reductase. Mol. Cell. Biol. 9:4932-4940.
13. Filiatrault MJ, Picardo KF, Ngai H, Passador L, Iglewski BH. 2006. Identification of Pseudomonas aeruginosa genes involved in virulence and anaerobic growth. Infect. Immun. 74:4237-4245.
14. Filiatrault MJ, et al. 2005. Effect of anaerobiosis and nitrate on gene expression in Pseudomonas aeruginosa. Infect. Immun. 73:3764-3772.
15. Filpula D, Fuchs JA. 1979. Increased synthesis of ribonucleotide reductase after deoxyribonucleic acid inhibition in various species of bacteria. J. Bacteriol. 139:694-696.
16. Formanek W, et al. 2002. Elevated nitrite in breath condensates of children with respiratory disease. Eur. Respir. J. 19:487-491.
17. Gotoh H, et al. 2008. Pseudomonas aeruginosa, under DNA replication inhibition, tends to form biofilms via Arr. Res. Microbiol. 159:294-302.
18. Haskin CJ, Ravi N, Lynch JB, Munck E, Que L, Jr. 1995. Reaction of NO with the reduced R2 protein of ribonucleotide reductase from Escherichia coli. Biochemistry 34:11090-11098.
19. Heldt D, et al. 2005. Aerobic synthesis of vitamin B12: ring contraction and cobalt chelation. Biochem. Soc. Trans. 33:815-819.
20. Herrick J, Sclavi B. 2007. Ribonucleotide reductase and the regulation of DNA replication: an old story and an ancient heritage. Mol. Microbiol. 63:22-34.
21. Hoffman LR, et al. 2010. Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog. 6:e1000712.
22. Horak F, Jr, et al. 2007. Longitudinal monitoring of pediatric cystic fibrosis lung disease using nitrite in exhaled breath condensate. Pediatr. Pulmonol. 42:1198-1206.
23. Jordan A, et al. 1997. B12-dependent ribonucleotide reductases from deeply rooted eubacteria are structurally related to the aerobic enzyme from Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 94:13487-13492.
24. Jordan A, et al. 1999. Ribonucleotide reduction in Pseudomonas species: simultaneous presence of active enzymes from different classes. J. Bacteriol. 181:3974-3980.
25. Lindemans J, Neijens HJ, Kerrebijn KF, Abels J. 1984. Vitamin B12 absorption in cystic fibrosis. Acta Paediatr. Scand. 73:537-540.
26. Linnane SJ, et al. 1998. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am. J. Respir. Crit. Care Med. 158:207-212.
27. Odsbu I, Morigen Skarstad K. 2009. A reduction in ribonucleotide reductase activity slows down the chromosome replication fork but does not change its localization. PLoS One 4:e7617.
28. Ojoo JC, Mulrennan SA, Kastelik JA, Morice AH, Redington AE. 2005. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax 60:22-26.
29. O'May CY, Reid DW, Kirov SM. 2006. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. FEMS Immunol. Med. Microbiol. 48:373-380.
30. O'Toole GA, Kolter R. 1998. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30:295-304.
31. Ozer I, Ozcetin M, Karaer H, Kurt SG, Sahin S. 2011. Retrospective approach to methylenetetrahydrofolate reductase mutations in children. Pediatr. Neurol. 45:34-38.
32. Palmer KL, Brown SA, Whiteley M. 2007. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J. Bacteriol. 189:4449-4455.
33. Parsek MR, Tolker-Nielsen T. 2008. Pattern formation in Pseudomonas aeruginosa biofilms. Curr. Opin. Microbiol. 11:560-566.
34. Philippe N, Alcaraz JP, Coursange E, Geiselmann J, Schneider D. 2004. Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria. Plasmid 51:246-255.
35. Prozorov AA. 2005. The bacterial cell cycle: DNA replication, nucleoid segregation, and cell division. Mikrobiologiia 74:437-451. (In Russian.)
36. Raux E, Schubert HL, Warren MJ. 2000. Biosynthesis of cobalamin (vitamin B12): a bacterial conundrum. Cell. Mol. Life Sci. 57:1880-1893.
37. Rogers GB, et al. 2004. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. J. Clin. Microbiol. 42:5176-5183.
38. Roth JR, Lawrence JG, Rubenfield M, Kieffer-Higgins S, Church GM. 1993. Characterization of the cobalamin (vitamin B12) biosynthetic genes of Salmonella typhimurium. J. Bacteriol. 175:3303-3316.
39. Roy B, Lepoivre M, Henry Y, Fontecave M. 1995. Inhibition of ribonucleotide reductase by nitric oxide derived from thionitrites: reversible modifications of both subunits. Biochemistry 34:5411-5418.
40. Ryder C, Byrd M, Wozniak DJ. 2007. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr. Opin. Microbiol. 10: 644-648.
41. Sauer K, et al. 2004. Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J. Bacteriol. 186:7312-7326.
42. Schapiro JM, Libby SJ, Fang FC. 2003. Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress. Proc. Natl. Acad. Sci. U. S. A. 100:8496-8501.
43. Schobert M, Jahn D. 2010. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Int. J. Med. Microbiol. 300:549-556.
44. Schreiber K, et al. 2007. The anaerobic regulatory network required for Pseudomonas aeruginosa nitrate respiration. J. Bacteriol. 189:4310-4314.
45. Sias SR, Stouthamer AH, Ingraham JL. 1980. The assimilatory and dissimilatory nitrate reductases of Pseudomonas aeruginosa are encoded by different genes. J. Gen. Microbiol. 118:229-234.
46. Sjöberg BM, Torrents E. 2011. Shift in ribonucleotide reductase gene expression in Pseudomonas aerginosa during infection. Infect. Immun. 79:2663-2669.
47. Smith A. 1997. Pathogenesis of bacterial bronchitis in cystic fibrosis. Pediatr. Infect. Dis. J. 16:91-95.
48. Sriramulu DD, Lunsdorf H, Lam JS, Romling U. 2005. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J. Med. Microbiol. 54:667-676.
49. Stover CK, et al. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
50. Torheim NK, Boye E, Lobner-Olesen A, Stokke T, Skarstad K. 2000. The Escherichia coli SeqA protein destabilizes mutant DnaA204 protein. Mol. Microbiol. 37:629-638.
51. Torrents E, Poplawski A, Sjoberg BM. 2005. Two proteins mediate class II ribonucleotide reductase activity in Pseudomonas aeruginosa: expression and transcriptional analysis of the aerobic enzymes. J. Biol. Chem. 280:16571-16578.
52. Toyofuku M, et al. 2007. Quorum sensing regulates denitrification in Pseudomonas aeruginosa PAO1. J. Bacteriol. 189:4969-4972.
53. Trunk K, et al. 2010. Anaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulons. Environ. Microbiol. 12:1719-1733.
54. Tunney MM, et al. 2008. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 177:995-1001.
55. von Drygalski A, Biller J. 2008. Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency. Nutr. Clin. Pract. 23:557-563.
56. Winteler HV, Haas D. 1996. The homologous regulators ANR of Pseudomonas aeruginosa and FNR of Escherichia coli have overlapping but distinct specificities for anaerobically inducible promoters. Microbiology 142(Pt 3):685-693.
57. Worlitzsch D, et al. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325.
58. Yoon MY, Lee KM, Park Y, Yoon SS. 2011. Contribution of cell elongation to the biofilm formation of Pseudomonas aeruginosa during anaerobic respiration. PLoS One 6:e16105.
59. Yoon SS, et al. 2006. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J. Clin. Invest. 116:436-446.
60. Yoon SS, Hassett DJ. 2004. Chronic Pseudomonas aeruginosa infection in cystic fibrosis airway disease: metabolic changes that unravel novel drug targets. Expert Rev. Anti Infect. Ther. 2:611-623.
61. Yoon SS, et al. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593-603.
62. Yoon SS, et al. 2007. Two-pronged survival strategy for the major cystic fibrosis pathogen, Pseudomonas aeruginosa, lacking the capacity to degrade nitric oxide during anaerobic respiration. EMBO J. 26:3662-3672.
63. Zimmermann A, Reimmann C, Galimand M, Haas D. 1991. Anaerobic growth and cyanide synthesis of Pseudomonas aeruginosa depend on anr, a regulatory gene homologous with fnr of Escherichia coli. Mol. Microbiol. 5:1483-1490.